4.8 Letter

Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury

Related references

Note: Only part of the references are listed.
Article Critical Care Medicine

CXCL10-CXCR3 Enhances the Development of Neutrophil-mediated Fulminant Lung Injury of Viral and Nonviral Origin

Akihiko Ichikawa et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Article Medicine, General & Internal

Clinical Characteristics and 30-Day Outcomes for Influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) Infections

Edward A. Belongia et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)

Article Medicine, General & Internal

Factors Associated With Death or Hospitalization Due to Pandemic 2009 Influenza A(H1N1) Infection in California

Janice K. Louie et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

Article Biology

Influenza A virus H5N1 entry into host cells is through clathrin-dependent endocytosis

Wang HongLiang et al.

SCIENCE IN CHINA SERIES C-LIFE SCIENCES (2009)

Article Critical Care Medicine

Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza

Jesus F. Bermejo-Martin et al.

CRITICAL CARE (2009)

Article Biochemistry & Molecular Biology

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

Menno D. de Jong et al.

NATURE MEDICINE (2006)